实践中的全球航空公司:梅波利祖马布与FESS或没有FESS对CRSwNP患者2型炎症的长期影响
Jens Tidemandsen1, Vibeke Backer1,2, Anne Sophie Homøe1
1Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital, , Denmark.
International forum of allergy & rhinology
|December 15, 2025
概括
梅波利祖马布通过减少呼吸道炎症,有效治疗具有鼻息肉 (CRSwNP) 的慢性鼻炎和喘. 功能性内镜外科手术 (FESS) 在CRSwNP患者中提供额外的局部症状缓解.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 带鼻息肉的慢性鼻炎 (CRSwNP) 是一种2型炎症状况,经常与喘同时发生.
- 全球气道假设假设上空气道和下空气道之间的双向炎症.
- 梅波利祖马布 (抗IL-5) 提供全身治疗,而功能性内镜外科手术 (FESS) 针对鼻疾病,可能改善喘.
研究的目的:
- 评估梅波利祖马布 (含或不含FESS) 对严重CRSwNP的呼吸道炎症,肺功能和症状负担的影响.
- 评估针对性治疗在CRSwNP患者的有效性,有或没有喘.
主要方法:
- 一项随机对照试验 (RCT) 涉及58名严重CRSwNP.患者.
- 患者接受了单独的梅波利祖马布或与FESS结合的梅波利祖马布.
- 对血液,鼻和支气管在基线,6个月和12个月的炎症和症状结果的分析,按炎症子组分层.
主要成果:
- 两组治疗都显著改善了肺功能 (FEV1%,FVC%),并减少了炎症标志物 (FeNO,血液和鼻等).
- 在两组中,所有患者报告的结果都得到改善.
- 与单独使用梅波利祖马布相比,梅波利祖马布加FESS在鼻息肉得分,鼻塞和整体症状负担方面表现出更高的收益.
结论:
- 梅波利祖马布治疗显著改善了CRSwNP的上下呼吸道炎症和症状.
- 在不改变下呼吸道炎症的情况下,FESS为鼻腔症状提供了额外的局部益处.
- 支持针对全身和局部2型炎症的综合战略,以管理全球呼吸道疾病.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
919
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
919


